Global Personalized Medicines In Oncology Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Personalized Medicines In Oncology market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicines In Oncology is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicines In Oncology market. Personalized Medicines In Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicines In Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicines In Oncology market.
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Personalized Medicines In Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicines In Oncology market. It may include historical data, market segmentation by Type (e.g., Molecular Oncopathology, Genome Diagnostics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicines In Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicines In Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicines In Oncology industry. This include advancements in Personalized Medicines In Oncology technology, Personalized Medicines In Oncology new entrants, Personalized Medicines In Oncology new investment, and other innovations that are shaping the future of Personalized Medicines In Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicines In Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicines In Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicines In Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicines In Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicines In Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicines In Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicines In Oncology market.
Market Segmentation:
Personalized Medicines In Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Personalized Medicines In Oncology market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicines In Oncology is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicines In Oncology market. Personalized Medicines In Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicines In Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicines In Oncology market.
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Personalized Medicines In Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicines In Oncology market. It may include historical data, market segmentation by Type (e.g., Molecular Oncopathology, Genome Diagnostics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicines In Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicines In Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicines In Oncology industry. This include advancements in Personalized Medicines In Oncology technology, Personalized Medicines In Oncology new entrants, Personalized Medicines In Oncology new investment, and other innovations that are shaping the future of Personalized Medicines In Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicines In Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicines In Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicines In Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicines In Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicines In Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicines In Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicines In Oncology market.
Market Segmentation:
Personalized Medicines In Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Molecular Oncopathology
- Genome Diagnostics
- Radiation Therapy
- Oncology Testing
- Chemotherapy
- Others
- Research Centers
- Governmental Institutions
- Hospitals
- Clinical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biotheranostics
- Illumina
- DNA Link
- Genomic Health, Inc.(Exact Sciences)
- Cypher Genomics(Human Longevity, Inc.)
- Life Technologies Corporation(Thermo Fisher Scientific)
- Fulgent Genetics
- Caris Life Sciences
- Ariana Pharma
- Abbott Laboratories
- deCODE genetics
- Exagen Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicines In Oncology Market Size 2019-2030
2.1.2 Personalized Medicines In Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicines In Oncology Segment by Type
2.2.1 Molecular Oncopathology
2.2.2 Genome Diagnostics
2.2.3 Radiation Therapy
2.2.4 Oncology Testing
2.2.5 Chemotherapy
2.2.6 Others
2.3 Personalized Medicines In Oncology Market Size by Type
2.3.1 Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicines In Oncology Segment by Application
2.4.1 Research Centers
2.4.2 Governmental Institutions
2.4.3 Hospitals
2.4.4 Clinical Centers
2.4.5 Others
2.5 Personalized Medicines In Oncology Market Size by Application
2.5.1 Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINES IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Personalized Medicines In Oncology Market Size Market Share by Players
3.1.1 Global Personalized Medicines In Oncology Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicines In Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINES IN ONCOLOGY BY REGIONS
4.1 Personalized Medicines In Oncology Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.3 APAC Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.4 Europe Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicines In Oncology Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicines In Oncology Market Size by Country (2019-2024)
5.2 Americas Personalized Medicines In Oncology Market Size by Type (2019-2024)
5.3 Americas Personalized Medicines In Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicines In Oncology Market Size by Region (2019-2024)
6.2 APAC Personalized Medicines In Oncology Market Size by Type (2019-2024)
6.3 APAC Personalized Medicines In Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicines In Oncology by Country (2019-2024)
7.2 Europe Personalized Medicines In Oncology Market Size by Type (2019-2024)
7.3 Europe Personalized Medicines In Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicines In Oncology by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET FORECAST
10.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicines In Oncology Forecast
10.1.3 APAC Personalized Medicines In Oncology Forecast
10.1.4 Europe Personalized Medicines In Oncology Forecast
10.1.5 Middle East & Africa Personalized Medicines In Oncology Forecast
10.2 Americas Personalized Medicines In Oncology Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicines In Oncology Market Forecast
10.2.2 Canada Personalized Medicines In Oncology Market Forecast
10.2.3 Mexico Personalized Medicines In Oncology Market Forecast
10.2.4 Brazil Personalized Medicines In Oncology Market Forecast
10.3 APAC Personalized Medicines In Oncology Forecast by Region (2025-2030)
10.3.1 China Personalized Medicines In Oncology Market Forecast
10.3.2 Japan Personalized Medicines In Oncology Market Forecast
10.3.3 Korea Personalized Medicines In Oncology Market Forecast
10.3.4 Southeast Asia Personalized Medicines In Oncology Market Forecast
10.3.5 India Personalized Medicines In Oncology Market Forecast
10.3.6 Australia Personalized Medicines In Oncology Market Forecast
10.4 Europe Personalized Medicines In Oncology Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicines In Oncology Market Forecast
10.4.2 France Personalized Medicines In Oncology Market Forecast
10.4.3 UK Personalized Medicines In Oncology Market Forecast
10.4.4 Italy Personalized Medicines In Oncology Market Forecast
10.4.5 Russia Personalized Medicines In Oncology Market Forecast
10.5 Middle East & Africa Personalized Medicines In Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicines In Oncology Market Forecast
10.5.2 South Africa Personalized Medicines In Oncology Market Forecast
10.5.3 Israel Personalized Medicines In Oncology Market Forecast
10.5.4 Turkey Personalized Medicines In Oncology Market Forecast
10.5.5 GCC Countries Personalized Medicines In Oncology Market Forecast
10.6 Global Personalized Medicines In Oncology Forecast by Type (2025-2030)
10.7 Global Personalized Medicines In Oncology Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biotheranostics
11.1.1 Biotheranostics Company Information
11.1.2 Biotheranostics Personalized Medicines In Oncology Product Offered
11.1.3 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biotheranostics Main Business Overview
11.1.5 Biotheranostics Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Personalized Medicines In Oncology Product Offered
11.2.3 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 DNA Link
11.3.1 DNA Link Company Information
11.3.2 DNA Link Personalized Medicines In Oncology Product Offered
11.3.3 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DNA Link Main Business Overview
11.3.5 DNA Link Latest Developments
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Information
11.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Genomic Health, Inc.(Exact Sciences) Main Business Overview
11.4.5 Genomic Health, Inc.(Exact Sciences) Latest Developments
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Information
11.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cypher Genomics(Human Longevity, Inc.) Main Business Overview
11.5.5 Cypher Genomics(Human Longevity, Inc.) Latest Developments
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Information
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Main Business Overview
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Information
11.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Offered
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fulgent Genetics Main Business Overview
11.7.5 Fulgent Genetics Latest Developments
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Information
11.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Offered
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Caris Life Sciences Main Business Overview
11.8.5 Caris Life Sciences Latest Developments
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Information
11.9.2 Ariana Pharma Personalized Medicines In Oncology Product Offered
11.9.3 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ariana Pharma Main Business Overview
11.9.5 Ariana Pharma Latest Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Information
11.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Offered
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Abbott Laboratories Main Business Overview
11.10.5 Abbott Laboratories Latest Developments
11.11 deCODE genetics
11.11.1 deCODE genetics Company Information
11.11.2 deCODE genetics Personalized Medicines In Oncology Product Offered
11.11.3 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 deCODE genetics Main Business Overview
11.11.5 deCODE genetics Latest Developments
11.12 Exagen Inc
11.12.1 Exagen Inc Company Information
11.12.2 Exagen Inc Personalized Medicines In Oncology Product Offered
11.12.3 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exagen Inc Main Business Overview
11.12.5 Exagen Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicines In Oncology Market Size 2019-2030
2.1.2 Personalized Medicines In Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicines In Oncology Segment by Type
2.2.1 Molecular Oncopathology
2.2.2 Genome Diagnostics
2.2.3 Radiation Therapy
2.2.4 Oncology Testing
2.2.5 Chemotherapy
2.2.6 Others
2.3 Personalized Medicines In Oncology Market Size by Type
2.3.1 Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicines In Oncology Segment by Application
2.4.1 Research Centers
2.4.2 Governmental Institutions
2.4.3 Hospitals
2.4.4 Clinical Centers
2.4.5 Others
2.5 Personalized Medicines In Oncology Market Size by Application
2.5.1 Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINES IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Personalized Medicines In Oncology Market Size Market Share by Players
3.1.1 Global Personalized Medicines In Oncology Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicines In Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINES IN ONCOLOGY BY REGIONS
4.1 Personalized Medicines In Oncology Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.3 APAC Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.4 Europe Personalized Medicines In Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicines In Oncology Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicines In Oncology Market Size by Country (2019-2024)
5.2 Americas Personalized Medicines In Oncology Market Size by Type (2019-2024)
5.3 Americas Personalized Medicines In Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicines In Oncology Market Size by Region (2019-2024)
6.2 APAC Personalized Medicines In Oncology Market Size by Type (2019-2024)
6.3 APAC Personalized Medicines In Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicines In Oncology by Country (2019-2024)
7.2 Europe Personalized Medicines In Oncology Market Size by Type (2019-2024)
7.3 Europe Personalized Medicines In Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicines In Oncology by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET FORECAST
10.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicines In Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicines In Oncology Forecast
10.1.3 APAC Personalized Medicines In Oncology Forecast
10.1.4 Europe Personalized Medicines In Oncology Forecast
10.1.5 Middle East & Africa Personalized Medicines In Oncology Forecast
10.2 Americas Personalized Medicines In Oncology Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicines In Oncology Market Forecast
10.2.2 Canada Personalized Medicines In Oncology Market Forecast
10.2.3 Mexico Personalized Medicines In Oncology Market Forecast
10.2.4 Brazil Personalized Medicines In Oncology Market Forecast
10.3 APAC Personalized Medicines In Oncology Forecast by Region (2025-2030)
10.3.1 China Personalized Medicines In Oncology Market Forecast
10.3.2 Japan Personalized Medicines In Oncology Market Forecast
10.3.3 Korea Personalized Medicines In Oncology Market Forecast
10.3.4 Southeast Asia Personalized Medicines In Oncology Market Forecast
10.3.5 India Personalized Medicines In Oncology Market Forecast
10.3.6 Australia Personalized Medicines In Oncology Market Forecast
10.4 Europe Personalized Medicines In Oncology Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicines In Oncology Market Forecast
10.4.2 France Personalized Medicines In Oncology Market Forecast
10.4.3 UK Personalized Medicines In Oncology Market Forecast
10.4.4 Italy Personalized Medicines In Oncology Market Forecast
10.4.5 Russia Personalized Medicines In Oncology Market Forecast
10.5 Middle East & Africa Personalized Medicines In Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicines In Oncology Market Forecast
10.5.2 South Africa Personalized Medicines In Oncology Market Forecast
10.5.3 Israel Personalized Medicines In Oncology Market Forecast
10.5.4 Turkey Personalized Medicines In Oncology Market Forecast
10.5.5 GCC Countries Personalized Medicines In Oncology Market Forecast
10.6 Global Personalized Medicines In Oncology Forecast by Type (2025-2030)
10.7 Global Personalized Medicines In Oncology Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biotheranostics
11.1.1 Biotheranostics Company Information
11.1.2 Biotheranostics Personalized Medicines In Oncology Product Offered
11.1.3 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biotheranostics Main Business Overview
11.1.5 Biotheranostics Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Personalized Medicines In Oncology Product Offered
11.2.3 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 DNA Link
11.3.1 DNA Link Company Information
11.3.2 DNA Link Personalized Medicines In Oncology Product Offered
11.3.3 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DNA Link Main Business Overview
11.3.5 DNA Link Latest Developments
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Information
11.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Genomic Health, Inc.(Exact Sciences) Main Business Overview
11.4.5 Genomic Health, Inc.(Exact Sciences) Latest Developments
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Information
11.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cypher Genomics(Human Longevity, Inc.) Main Business Overview
11.5.5 Cypher Genomics(Human Longevity, Inc.) Latest Developments
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Information
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Main Business Overview
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Information
11.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Offered
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fulgent Genetics Main Business Overview
11.7.5 Fulgent Genetics Latest Developments
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Information
11.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Offered
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Caris Life Sciences Main Business Overview
11.8.5 Caris Life Sciences Latest Developments
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Information
11.9.2 Ariana Pharma Personalized Medicines In Oncology Product Offered
11.9.3 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ariana Pharma Main Business Overview
11.9.5 Ariana Pharma Latest Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Information
11.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Offered
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Abbott Laboratories Main Business Overview
11.10.5 Abbott Laboratories Latest Developments
11.11 deCODE genetics
11.11.1 deCODE genetics Company Information
11.11.2 deCODE genetics Personalized Medicines In Oncology Product Offered
11.11.3 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 deCODE genetics Main Business Overview
11.11.5 deCODE genetics Latest Developments
11.12 Exagen Inc
11.12.1 Exagen Inc Company Information
11.12.2 Exagen Inc Personalized Medicines In Oncology Product Offered
11.12.3 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exagen Inc Main Business Overview
11.12.5 Exagen Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Personalized Medicines In Oncology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Molecular Oncopathology
Table 3. Major Players of Genome Diagnostics
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of Oncology Testing
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Others
Table 8. Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 11. Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 14. Global Personalized Medicines In Oncology Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Personalized Medicines In Oncology Revenue Market Share by Player (2019-2024)
Table 16. Personalized Medicines In Oncology Key Players Head office and Products Offered
Table 17. Personalized Medicines In Oncology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Personalized Medicines In Oncology Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Personalized Medicines In Oncology Market Size Market Share by Regions (2019-2024)
Table 22. Global Personalized Medicines In Oncology Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Personalized Medicines In Oncology Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Personalized Medicines In Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Personalized Medicines In Oncology Market Size Market Share by Country (2019-2024)
Table 26. Americas Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 28. Americas Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 30. APAC Personalized Medicines In Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Table 32. APAC Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 34. APAC Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 36. Europe Personalized Medicines In Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Personalized Medicines In Oncology Market Size Market Share by Country (2019-2024)
Table 38. Europe Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 40. Europe Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Personalized Medicines In Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Personalized Medicines In Oncology
Table 49. Key Market Challenges & Risks of Personalized Medicines In Oncology
Table 50. Key Industry Trends of Personalized Medicines In Oncology
Table 51. Global Personalized Medicines In Oncology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Personalized Medicines In Oncology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Personalized Medicines In Oncology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Biotheranostics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 56. Biotheranostics Personalized Medicines In Oncology Product Offered
Table 57. Biotheranostics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Biotheranostics Main Business
Table 59. Biotheranostics Latest Developments
Table 60. Illumina Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 61. Illumina Personalized Medicines In Oncology Product Offered
Table 62. Illumina Main Business
Table 63. Illumina Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Illumina Latest Developments
Table 65. DNA Link Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 66. DNA Link Personalized Medicines In Oncology Product Offered
Table 67. DNA Link Main Business
Table 68. DNA Link Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. DNA Link Latest Developments
Table 70. Genomic Health, Inc.(Exact Sciences) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 71. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
Table 72. Genomic Health, Inc.(Exact Sciences) Main Business
Table 73. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Genomic Health, Inc.(Exact Sciences) Latest Developments
Table 75. Cypher Genomics(Human Longevity, Inc.) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 76. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
Table 77. Cypher Genomics(Human Longevity, Inc.) Main Business
Table 78. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cypher Genomics(Human Longevity, Inc.) Latest Developments
Table 80. Life Technologies Corporation(Thermo Fisher Scientific) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 81. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
Table 82. Life Technologies Corporation(Thermo Fisher Scientific) Main Business
Table 83. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
Table 85. Fulgent Genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 86. Fulgent Genetics Personalized Medicines In Oncology Product Offered
Table 87. Fulgent Genetics Main Business
Table 88. Fulgent Genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Fulgent Genetics Latest Developments
Table 90. Caris Life Sciences Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 91. Caris Life Sciences Personalized Medicines In Oncology Product Offered
Table 92. Caris Life Sciences Main Business
Table 93. Caris Life Sciences Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Caris Life Sciences Latest Developments
Table 95. Ariana Pharma Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 96. Ariana Pharma Personalized Medicines In Oncology Product Offered
Table 97. Ariana Pharma Main Business
Table 98. Ariana Pharma Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Ariana Pharma Latest Developments
Table 100. Abbott Laboratories Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 101. Abbott Laboratories Personalized Medicines In Oncology Product Offered
Table 102. Abbott Laboratories Main Business
Table 103. Abbott Laboratories Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Abbott Laboratories Latest Developments
Table 105. deCODE genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 106. deCODE genetics Personalized Medicines In Oncology Product Offered
Table 107. deCODE genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. deCODE genetics Main Business
Table 109. deCODE genetics Latest Developments
Table 110. Exagen Inc Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 111. Exagen Inc Personalized Medicines In Oncology Product Offered
Table 112. Exagen Inc Main Business
Table 113. Exagen Inc Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Exagen Inc Latest Developments
Table 1. Personalized Medicines In Oncology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Molecular Oncopathology
Table 3. Major Players of Genome Diagnostics
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of Oncology Testing
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Others
Table 8. Personalized Medicines In Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 11. Personalized Medicines In Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 14. Global Personalized Medicines In Oncology Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Personalized Medicines In Oncology Revenue Market Share by Player (2019-2024)
Table 16. Personalized Medicines In Oncology Key Players Head office and Products Offered
Table 17. Personalized Medicines In Oncology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Personalized Medicines In Oncology Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Personalized Medicines In Oncology Market Size Market Share by Regions (2019-2024)
Table 22. Global Personalized Medicines In Oncology Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Personalized Medicines In Oncology Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Personalized Medicines In Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Personalized Medicines In Oncology Market Size Market Share by Country (2019-2024)
Table 26. Americas Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 28. Americas Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 30. APAC Personalized Medicines In Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Table 32. APAC Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 34. APAC Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 36. Europe Personalized Medicines In Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Personalized Medicines In Oncology Market Size Market Share by Country (2019-2024)
Table 38. Europe Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 40. Europe Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Personalized Medicines In Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Personalized Medicines In Oncology
Table 49. Key Market Challenges & Risks of Personalized Medicines In Oncology
Table 50. Key Industry Trends of Personalized Medicines In Oncology
Table 51. Global Personalized Medicines In Oncology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Personalized Medicines In Oncology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Personalized Medicines In Oncology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Biotheranostics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 56. Biotheranostics Personalized Medicines In Oncology Product Offered
Table 57. Biotheranostics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Biotheranostics Main Business
Table 59. Biotheranostics Latest Developments
Table 60. Illumina Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 61. Illumina Personalized Medicines In Oncology Product Offered
Table 62. Illumina Main Business
Table 63. Illumina Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Illumina Latest Developments
Table 65. DNA Link Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 66. DNA Link Personalized Medicines In Oncology Product Offered
Table 67. DNA Link Main Business
Table 68. DNA Link Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. DNA Link Latest Developments
Table 70. Genomic Health, Inc.(Exact Sciences) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 71. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offered
Table 72. Genomic Health, Inc.(Exact Sciences) Main Business
Table 73. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Genomic Health, Inc.(Exact Sciences) Latest Developments
Table 75. Cypher Genomics(Human Longevity, Inc.) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 76. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offered
Table 77. Cypher Genomics(Human Longevity, Inc.) Main Business
Table 78. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cypher Genomics(Human Longevity, Inc.) Latest Developments
Table 80. Life Technologies Corporation(Thermo Fisher Scientific) Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 81. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offered
Table 82. Life Technologies Corporation(Thermo Fisher Scientific) Main Business
Table 83. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Life Technologies Corporation(Thermo Fisher Scientific) Latest Developments
Table 85. Fulgent Genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 86. Fulgent Genetics Personalized Medicines In Oncology Product Offered
Table 87. Fulgent Genetics Main Business
Table 88. Fulgent Genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Fulgent Genetics Latest Developments
Table 90. Caris Life Sciences Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 91. Caris Life Sciences Personalized Medicines In Oncology Product Offered
Table 92. Caris Life Sciences Main Business
Table 93. Caris Life Sciences Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Caris Life Sciences Latest Developments
Table 95. Ariana Pharma Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 96. Ariana Pharma Personalized Medicines In Oncology Product Offered
Table 97. Ariana Pharma Main Business
Table 98. Ariana Pharma Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Ariana Pharma Latest Developments
Table 100. Abbott Laboratories Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 101. Abbott Laboratories Personalized Medicines In Oncology Product Offered
Table 102. Abbott Laboratories Main Business
Table 103. Abbott Laboratories Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Abbott Laboratories Latest Developments
Table 105. deCODE genetics Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 106. deCODE genetics Personalized Medicines In Oncology Product Offered
Table 107. deCODE genetics Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. deCODE genetics Main Business
Table 109. deCODE genetics Latest Developments
Table 110. Exagen Inc Details, Company Type, Personalized Medicines In Oncology Area Served and Its Competitors
Table 111. Exagen Inc Personalized Medicines In Oncology Product Offered
Table 112. Exagen Inc Main Business
Table 113. Exagen Inc Personalized Medicines In Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Exagen Inc Latest Developments
LIST OF FIGURES
Figure 1. Personalized Medicines In Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicines In Oncology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicines In Oncology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicines In Oncology Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicines In Oncology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicines In Oncology Market Size Market Share by Type in 2023
Figure 10. Personalized Medicines In Oncology in Research Centers
Figure 11. Global Personalized Medicines In Oncology Market: Research Centers (2019-2024) & ($ Millions)
Figure 12. Personalized Medicines In Oncology in Governmental Institutions
Figure 13. Global Personalized Medicines In Oncology Market: Governmental Institutions (2019-2024) & ($ Millions)
Figure 14. Personalized Medicines In Oncology in Hospitals
Figure 15. Global Personalized Medicines In Oncology Market: Hospitals (2019-2024) & ($ Millions)
Figure 16. Personalized Medicines In Oncology in Clinical Centers
Figure 17. Global Personalized Medicines In Oncology Market: Clinical Centers (2019-2024) & ($ Millions)
Figure 18. Personalized Medicines In Oncology in Others
Figure 19. Global Personalized Medicines In Oncology Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Personalized Medicines In Oncology Market Size Market Share by Application in 2023
Figure 21. Global Personalized Medicines In Oncology Revenue Market Share by Player in 2023
Figure 22. Global Personalized Medicines In Oncology Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 24. APAC Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 25. Europe Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 27. Americas Personalized Medicines In Oncology Value Market Share by Country in 2023
Figure 28. United States Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Personalized Medicines In Oncology Market Size Market Share by Region in 2023
Figure 33. APAC Personalized Medicines In Oncology Market Size Market Share by Type in 2023
Figure 34. APAC Personalized Medicines In Oncology Market Size Market Share by Application in 2023
Figure 35. China Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Personalized Medicines In Oncology Market Size Market Share by Country in 2023
Figure 42. Europe Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Figure 43. Europe Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Figure 44. Germany Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 58. APAC Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 59. Europe Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 61. United States Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 62. Canada Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 65. China Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 66. Japan Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 67. Korea Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 69. India Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 70. Australia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 71. Germany Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 72. France Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 73. UK Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 74. Italy Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 75. Russia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 76. Spain Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 79. Israel Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 82. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Personalized Medicines In Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicines In Oncology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicines In Oncology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicines In Oncology Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicines In Oncology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicines In Oncology Market Size Market Share by Type in 2023
Figure 10. Personalized Medicines In Oncology in Research Centers
Figure 11. Global Personalized Medicines In Oncology Market: Research Centers (2019-2024) & ($ Millions)
Figure 12. Personalized Medicines In Oncology in Governmental Institutions
Figure 13. Global Personalized Medicines In Oncology Market: Governmental Institutions (2019-2024) & ($ Millions)
Figure 14. Personalized Medicines In Oncology in Hospitals
Figure 15. Global Personalized Medicines In Oncology Market: Hospitals (2019-2024) & ($ Millions)
Figure 16. Personalized Medicines In Oncology in Clinical Centers
Figure 17. Global Personalized Medicines In Oncology Market: Clinical Centers (2019-2024) & ($ Millions)
Figure 18. Personalized Medicines In Oncology in Others
Figure 19. Global Personalized Medicines In Oncology Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Personalized Medicines In Oncology Market Size Market Share by Application in 2023
Figure 21. Global Personalized Medicines In Oncology Revenue Market Share by Player in 2023
Figure 22. Global Personalized Medicines In Oncology Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 24. APAC Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 25. Europe Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Personalized Medicines In Oncology Market Size 2019-2024 ($ Millions)
Figure 27. Americas Personalized Medicines In Oncology Value Market Share by Country in 2023
Figure 28. United States Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Personalized Medicines In Oncology Market Size Market Share by Region in 2023
Figure 33. APAC Personalized Medicines In Oncology Market Size Market Share by Type in 2023
Figure 34. APAC Personalized Medicines In Oncology Market Size Market Share by Application in 2023
Figure 35. China Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Personalized Medicines In Oncology Market Size Market Share by Country in 2023
Figure 42. Europe Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Figure 43. Europe Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Figure 44. Germany Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Personalized Medicines In Oncology Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Personalized Medicines In Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 58. APAC Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 59. Europe Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 61. United States Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 62. Canada Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 65. China Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 66. Japan Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 67. Korea Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 69. India Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 70. Australia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 71. Germany Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 72. France Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 73. UK Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 74. Italy Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 75. Russia Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 76. Spain Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 79. Israel Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Personalized Medicines In Oncology Market Size 2025-2030 ($ Millions)
Figure 82. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Personalized Medicines In Oncology Market Size Market Share Forecast by Application (2025-2030)
